Skip to main content

Table 4 The clinical and demographic information of the participants

From: Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population

  

Prostate cancer

n (%)

BPH

n (%)

Age

< 60

17 (16.5)

26 (26)

60–69

37 (35.9)

41 (41)

≥70

49 (47.6)

33 (33)

PSA (ng/ml)

≤4

13 (12.6)

19 (19)

4.1–10

47 (45.6)

56 (56)

> 10

43 (41.7)

25 (25)

Gleason score

< 7

14 (13.6)

–

7

47 (45.6)

–

≥8

42 (40.8)

–

Perineural invasion

+

65 (63.1)

–

–

38 (36.9)

–

Extra prostatic extension

+

18 (17.5)

–

–

85 (82.5)

–